| Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: An analysis of 112 consecutively treated patients M Dediu, O Ion, R Ion, A Alexandru, D Median, C Gal, T Horvat, C Motas, ... J BUON 17 (2), 317-322, 2012 | 12 | 2012 |
| The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study M Dediu, E Crisan, M Radut, A Tarlea, D Median, A Alexandru, G Vremes, ... Lung Cancer 63 (2), 271-276, 2009 | 12 | 2009 |
| Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast … EP Hamilton, JH Kim, N Eigeliene, D Mavroudis, DM Median, ... Journal of Clinical Oncology 41 (16_suppl), 501-501, 2023 | 11 | 2023 |
| Chemotherapy for breast cancer during pregnancy and postpartum: a retrospective descriptive study AA Simionescu, D Median Farmacia 63 (3), 417-421, 2015 | 7 | 2015 |
| Sentinel lymph node biopsy in breast cancer. principle, difficulties and pitfalls G Iancu, LM Mustata, R Cigaran, N Gica, R Botezatu, D Median, ... Chirurgia (Bucur) 116 (5), 533, 2021 | 6 | 2021 |
| Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: the emerging role of erlotinib. M Dediu, D Median, A Alexandru, G Vremes, C Gal Journal of BU ON.: Official Journal of the Balkan Union of Oncology 12, S137-49, 2007 | 5 | 2007 |
| Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients M Dediu, A Alexandru, D Median, R Anghel, A Tarlea, P Iorga, M Movanu JOURNAL-BALKAN UNION OF ONCOLOGY 11 (4), 425, 2006 | 5 | 2006 |
| Real-world data analysis of pregnancy-associated breast cancer at a tertiary-level hospital In Romania AA Simionescu, A Horobeț, L Belaşcu, DM Median Medicina 56 (10), 522, 2020 | 4 | 2020 |
| Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential M Dediu, D Median, A Alexandru, G Vremes, C Gal, M Gongu J BUON 14 (3), 375-379, 2009 | 4 | 2009 |
| COVID-19 pandemic impact on cord blood collection for stem cell use and actual perspectives MT Daia, D Median, NF Buinoiu, M Ciocarlan, G Iancu, AM Panaitescu, ... Maedica 16 (2), 184, 2021 | 3 | 2021 |
| 44O characterization of venous thromboembolic events (VTE), elevated aminotransferases (EAT) and interstitial lung disease (ILD) in monarchE M Toi, N Harbeck, JM Puig, J Cruz, JH Seo, M Takahashi, M Hulstijn, ... Annals of Oncology 32, S39-S40, 2021 | 2 | 2021 |
| Second primary breast cancer during PARP inhibitor treatment of somatic BRCA mutant ovarian cancer–a case report. DM Median, S Coniac, AI Miron Oncolog-Hematolog, 2023 | | 2023 |
| Hepatitis B Virus Reactivation in Oncological Patients who Underwent Chemotherapy. Filantropia Clinical Hospital Five Years’ Experience MT DAIA, D MEDIAN, NF BUINOIU, M CIOCARLAN, G IANCU, ... Maedica A Journal of Clinical Medicine 16 (2), 2021 | | 2021 |
| Breast conserving surgery in breast cancer after neoadjuvant chemotherapy–opportunity of radioopaque tumor marking clips G Iancu, L Mustata, L Tuinea, A Corha, B Median, G Peltecu, D Median European Journal of Cancer 138, S36-S37, 2020 | | 2020 |
| EP987 Prevalence and spectrum of BRCA mutations in patients with platinum-sensitive ovarian cancer from Romania–results of an observational study DL Stanculeanu, DM Median, CL Cebotaru, G Teodorescu, C Voinea International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
| EP208 Tumor infiltrating lymphocytes–marker of therapy response in breast cancer G Iancu, G Peltecu, D Terzea, D Median International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
| PREvalence of BRCA mutations and correlations with Demographic and clinical characteristICs in paTients with ovarian, fallopian tube or primary peritoneal cancer in Romania … CL Cebotaru, DL Stanculeanu, DM Median Annals of Oncology 29, vi34, 2018 | | 2018 |
| Borderline ovarian tumors-management. G Peltecu, AM Panaitescu, R Botezatu, N Gică, R Chirculescu, M Ionescu, ... Oncolog-Hematolog, 2018 | | 2018 |
| HEPATITIS B VIRUS REACTIVATION DURING CHEMOTHERAPY FOR BREAST CANCER. MT Daia, D Median, G Peltecu, A Streinu-Cercel, AM Panaitescu, ... Obstetrica si Ginecologie 66 (1), 2018 | | 2018 |
| PR60 Chemotherapy for breast cancer during pregnancy: case report series D Median, G Peltecu, G Iancu, A Simionescu, M Bari The Breast, S21, 2014 | | 2014 |
